Updating search results...

Search Resources

1 Result

View
Selected filters:
  • adjuvant-therapy
Zyflamend induces apoptosis in pancreatic cancer cells
Unrestricted Use
CC BY
Rating
0.0 stars

This resource is a video abstract of a research paper created by Research Square on behalf of its authors. It provides a synopsis that's easy to understand, and can be used to introduce the topics it covers to students, researchers, and the general public. The video's transcript is also provided in full, with a portion provided below for preview:

"Pancreatic neuroendocrine tumors, or PNETs, are a form of cancer that invade the hormone-producing cells in the pancreas. While many are benign, PNETs tend to behave unpredictably. And many treatments against malignant PNETs have proven ineffective. Now, a new study suggests that the anti-inflammatory herbal blend Zyflamend could be a promising treatment option. Experiments showed that Zyflamend reduces cell survival and induces cell death in pancreatic cancer cells in a dose-dependent manner. Zyflamend does so by inducing apoptosis, a programmed death sequence initiated by discarded cells. This form of cell death appears to be mediated by the JNK pathway, an important part of inflammatory responses in mammals. Although more work is needed to understand the full effects of this herbal blend in the clinic. These findings suggest that Zyflamend could be a novel add-on therapy for treating pancreatic cancer..."

The rest of the transcript, along with a link to the research itself, is available on the resource itself.

Subject:
Biology
Life Science
Material Type:
Diagram/Illustration
Reading
Provider:
Research Square
Provider Set:
Video Bytes
Date Added:
11/03/2020